Latest Insider Transactions at Bicycle Therapeutics PLC (BCYC)
This section provides a real-time view of insider transactions for Bicycle Therapeutics PLC (BCYC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BICYCLE THERAPEUTICS plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BICYCLE THERAPEUTICS plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 11
2024
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
6,256
-4.51%
|
$150,144
$24.99 P/Share
|
|
Nov 11
2024
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,575
+3.4%
|
$15,450
$6.63 P/Share
|
|
Oct 03
2024
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
153
-0.66%
|
$3,366
$22.26 P/Share
|
|
Oct 03
2024
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
972
-2.08%
|
$21,384
$22.26 P/Share
|
|
Oct 03
2024
|
Alistair Milnes CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
972
-1.36%
|
$21,384
$22.26 P/Share
|
|
Oct 03
2024
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct |
972
-1.04%
|
$21,384
$22.26 P/Share
|
|
Oct 03
2024
|
Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF |
SELL
Open market or private sale
|
Direct |
247
-1.09%
|
$5,434
$22.26 P/Share
|
|
Oct 03
2024
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,212
-0.84%
|
$70,664
$22.26 P/Share
|
|
Jul 03
2024
|
Alistair Milnes CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
967
-1.34%
|
$18,373
$19.64 P/Share
|
|
Jul 03
2024
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,194
-0.82%
|
$60,686
$19.64 P/Share
|
|
Jul 03
2024
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
779
-1.24%
|
$14,801
$19.64 P/Share
|
|
Jul 03
2024
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
967
-2.02%
|
$18,373
$19.64 P/Share
|
|
Jul 03
2024
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
148
-0.64%
|
$2,812
$19.64 P/Share
|
|
Jul 03
2024
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct |
967
-1.02%
|
$18,373
$19.64 P/Share
|
|
Jul 03
2024
|
Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF |
SELL
Open market or private sale
|
Direct |
246
-1.07%
|
$4,674
$19.64 P/Share
|
|
Jun 17
2024
|
Baker Bros. Advisors LP |
BUY
Conversion of derivative security
|
Indirect |
2,382,784
+20.07%
|
-
|
|
Apr 18
2024
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
24,000
+1.09%
|
-
|
|
Apr 11
2024
|
Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF |
SELL
Open market or private sale
|
Direct |
257
-1.11%
|
$5,654
$22.49 P/Share
|
|
Apr 03
2024
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
152
-0.65%
|
$3,496
$23.81 P/Share
|
|
Apr 03
2024
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
790
-1.24%
|
$18,170
$23.81 P/Share
|
|
Apr 03
2024
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
955
-1.96%
|
$21,965
$23.81 P/Share
|
|
Apr 03
2024
|
Alistair Milnes CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
955
-1.3%
|
$21,965
$23.81 P/Share
|
|
Apr 03
2024
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct |
955
-1.0%
|
$21,965
$23.81 P/Share
|
|
Apr 03
2024
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,158
-0.81%
|
$72,634
$23.81 P/Share
|
|
Feb 20
2024
|
Stephen H. Sands |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+50.0%
|
-
|
|
Feb 06
2024
|
Santiago Arroyo CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,660
+35.71%
|
-
|
|
Jan 03
2024
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,640
-3.99%
|
$44,880
$17.5 P/Share
|
|
Jan 03
2024
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
604
-2.52%
|
$10,268
$17.5 P/Share
|
|
Jan 03
2024
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
8,703
-2.18%
|
$147,951
$17.5 P/Share
|
|
Jan 03
2024
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct |
2,643
-2.68%
|
$44,931
$17.5 P/Share
|
|
Jan 03
2024
|
Alistair Milnes CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,643
-3.49%
|
$44,931
$17.5 P/Share
|
|
Jan 03
2024
|
Nigel Crockett CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
2,643
-5.15%
|
$44,931
$17.5 P/Share
|
|
Jan 02
2024
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+29.71%
|
-
|
|
Jan 02
2024
|
Pierre Legault Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+26.37%
|
-
|
|
Jan 02
2024
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+40.02%
|
-
|
|
Jan 02
2024
|
Richard N Kender Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+26.37%
|
-
|
|
Jan 02
2024
|
Gregory Paul Winter Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+3.21%
|
-
|
|
Jan 02
2024
|
Veronica Gh Jordan Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+26.37%
|
-
|
|
Jan 02
2024
|
Jose Carlos Gutierrez Ramos Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+26.37%
|
-
|
|
Jan 02
2024
|
Janice Bourque Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+26.37%
|
-
|
|
Jan 02
2024
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
77,000
+16.17%
|
-
|
|
Jan 02
2024
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+22.14%
|
-
|
|
Jan 02
2024
|
Alistair Milnes CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
39,000
+33.96%
|
-
|
|
Jan 02
2024
|
Alethia Young Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+50.0%
|
-
|
|
Jan 02
2024
|
Nigel Crockett CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+29.99%
|
-
|
|
Jan 02
2024
|
Santiago Arroyo CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,340
+50.0%
|
-
|
|
Oct 03
2023
|
Nicholas Keen CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
272
-0.71%
|
$5,440
$20.0 P/Share
|
|
Oct 03
2023
|
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
54
-0.67%
|
$1,080
$20.0 P/Share
|
|
Oct 03
2023
|
Michael Skynner CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct |
442
-0.62%
|
$8,840
$20.0 P/Share
|
|
Oct 03
2023
|
Kevin Lee CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,470
-0.45%
|
$29,400
$20.0 P/Share
|